Tag | Content |
---|
EnhancerAtlas ID | HS073-02942 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr12:8781110-8783140 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
BCL6 | MA0463.2 | chr12:8781875-8781891 | ATTTCTTAGAAAGCAA | - | 6.51 | BCL6B | MA0731.1 | chr12:8781873-8781890 | TTATTTCTTAGAAAGCA | - | 6.76 | FOXF2 | MA0030.1 | chr12:8781896-8781910 | CTTGTTTACCTTGC | - | 6.34 | ZNF263 | MA0528.1 | chr12:8782760-8782781 | TCCTATCCATCCTCCTGCTCC | - | 6.01 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_58852 | chr12:8730058-8820880 | Ly3 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH12I008628 | chr12 | 8781082 | 8783213 |
|
Enhancer Sequence | CTGTCCCTTT TTTTTTTTTT CTTTGAGGCA GGGTCTCACC CTGTCACCTA GGCTGGAGTG 60 CACTGGTGCA ATCATAGGTC ACTGCAGCCT CCAGCTCCTC AAGCAATCCT CCCACCTCAA 120 CCTCCTGAGT AGCTGGGACT ACTAACATGT GCCACCACAC CCAGCTAATT TTTGTATTTT 180 TTGTAGAGAC AAGGTTTCGC CATGTTTGCC CAAGCTAGTC TCAAACTCCT GGGTTTAATT 240 AATCTGCCTG CCTTGGCCTC CCAAAGTGCT GGGATTACAG GAGTGAGCCA CCACGCCCAG 300 CAGATCTGGC ACTGTCACTT AGGAAATGCA TGGCATTGGG AAAGAATTCC TTCCTCACAA 360 AGTCATCCTG ATGGTTTTCT TAGCTACTGT GTGGGAATAT GAAAGCGTGG CATCTGGGAT 420 ATGTAAAATA TGCTTGATAA AATTTCTCAT CTCTCCAGGT GACAGGAACA GCATGAGCTT 480 GTTGTCCTCA CAACCTTGCT GTTCCTGTCA TCTTCTCTCC AGGCGACAGG AACAGCAGGG 540 TTGTGAGGGC TTGCTTCTGA TACTTTAGCA ACTGTTTGAG CTCAGTCTGG TTTGAGTGAA 600 GGCTCATAGT AAAGCTATGA TTACATAAAA TTGAGATGTT ATTCATATTT TACATAATCT 660 TCTTAAGTAA AACTCTAATA AAATCCAGAG TTAACTAATT TACATGTAAC TATAAAGTTC 720 TTTATGTTAA GGAAACATGA TTTGTCCAGC ATAAGAAAAT ACTTTATTTC TTAGAAAGCA 780 ATATTCCTTG TTTACCTTGC TTCTTCTAAG GGAAGAAAAA TTATATCTCT TATAATTACA 840 GAATCATTTT CTGTTTTGGG GGATTTGGAG TTAGTGAGAC TAAAAAACAA TTTTGTGGGG 900 TTTCATTCAG CTATTAGTTA TTTTCCTTAC TAACTACTGT CTCCCCTCAC CAACTTCTAT 960 TGAAAAACCA CAGCACAACC TGGCTAGTTC ATTTTTAACA AAAATAACAT GACTTGGAAA 1020 TTGTGCTGCT GGTGCACATC TGGACTTCAC CACTTAATCC TCACCATGAG AAGCACGAGG 1080 TGAGGTTTCA TTATGGCCAC CGTGTGAAGC TAAAATGGGG ACTTCCCCTG GGAGTCTCCA 1140 GGGTGTACAT TCCTGTGTCT GAGGCCAGCA TGCTCCGGCA GTGACTCCCC AGGCCACTAT 1200 TTTTGGACAC CAGCTAGATT GTTCAATATG ATACTTTGTT GTTTTTAAAA AGAGCCCAAA 1260 AAGGAGTCTG TGTGGGTGAA AGTGTGATTT TTGGAGTGCT TCTACTTCTG CATTCCCCAA 1320 TTTTTGTTTT TCTCAGTTTA CTGCCAGCCA TATTATAGAA CTTCTCTGGG GTATGAAGAA 1380 GTTGAATGAC AGGCCTTTAT GCATATACAG GAATTACTCA TTCAACTTCT GCTGTGCAGC 1440 TGCCCAGGAC TCTTCAAGGA TGAGAGAACA GTAAACAAGA ATGCATCAAA AATCTAGGAC 1500 TGGGCAAAGG GCTAAAACAA AAGAATTATT TTTAATGGGA AAATGAACTA AGGAACCTCC 1560 TCTGATCATG AACATATAAG ACATAGAGTA GTGGGAAAAG TTAGGTTTTG TAATCTAGCA 1620 CGTAGAGATT TGAATTCTGT CTCCACCATT TCCTATCCAT CCTCCTGCTC CATATTTCTT 1680 TGAATGTGTT ACCTAATGTC ATATGTTTCA GTTCTTCCAT GTATAAAATG CGATCAAATA 1740 ATAGTGATAA TAGCTAACAT TTATTGTGTA CTTACTTTAT GGAAGATTCT GTGCTAAGCA 1800 CATTGCACAT AGTATCTCAT TTAAATCCAA GAGGTAGGAA CTATTATTAT TCCTATGTTC 1860 AGGCATAAAT ACTGAGGTGG CTTAGAGGTG AAACAAGTGT TTTGCAGGAT AGCTAAAGAT 1920 ATCGTAGGCC AGGCATGGAG GCTCACGACT GTAATCCCAG CACTTTGGGA AGCTGAGGCT 1980 GGTGGATCAC TTGAGGTCAG GAGTTTGAGA TCAGCCTGGG CTACATAGTG 2030
|